NCT07249983

Brief Summary

A prospective, two-phase interventional study evaluating the performance, safety, and usability of the SaCoVLM™ video laryngeal mask airway for airway management by military medics with limited intubation experience. The study includes simulation-based training and clinical application in sedated patients undergoing elective surgery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
8mo left

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Mar 2026Jan 2027

First Submitted

Initial submission to the registry

November 18, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 25, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

March 1, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

April 21, 2026

Status Verified

April 1, 2026

Enrollment Period

9 months

First QC Date

November 18, 2025

Last Update Submit

April 17, 2026

Conditions

Keywords

SaCoVLM™Video Laryngeal MaskMilitary Medic TrainingEmergency Airway

Outcome Measures

Primary Outcomes (2)

  • First-Attempt Success Rate of SaCoVLM™ Insertion

    Proportion of cases in which the SaCoVLM™ is successfully inserted on the first attempt during both simulated and clinical phases.

    Within 10 minutes of airway intervention.

  • First-Attempt Success Rate of Orotracheal Intubation via SaCoVLM™

    Proportion of successful orotracheal intubations on the first attempt using the SaCoVLM™ device as a conduit.

    Within 10 minutes following SaCoVLM™ placement.

Secondary Outcomes (5)

  • Time to SaCoVLM™ Insertion

    During initial airway management (simulation or clinical setting).

  • Time to Successful Intubation

    During initial airway management (simulation or clinical setting).

  • Glottic Visualization Score

    Immediately after SaCoVLM™ placement.

  • Subjective Difficulty Score

    Immediately after each procedure.

  • Incidence of Airway Complications

    From initiation of airway management to induction of general anesthesia (clinical phase only).

Study Arms (1)

Simulation and Clinical Phase

EXPERIMENTAL

Simulation-based and clinical use of SaCoVLM™ for airway management and intubation.

Device: SaCoVLM™ Video Laryngeal Mask

Interventions

Simulation-based and clinical use of SaCoVLM™ for airway management and intubation.

Simulation and Clinical Phase

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective surgery
  • ASA I-II
  • need for airway management

You may not qualify if:

  • Pregnancy
  • known airway abnormalities
  • allergy to anesthetics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Military University Hospital Prague

Prague, Prague, 16209, Czechia

RECRUITING

Related Publications (1)

  • Mishra N, Bharadwaj A. Comparison of Fiberoptic-Guided Tracheal Intubation Through Intubating Laryngeal Mask Airway (ILMA) FastrachTM and Ambu(R) Aura-i: A Randomized Clinical Study. Cureus. 2020 Sep 1;12(9):e10178. doi: 10.7759/cureus.10178.

    PMID: 33029458BACKGROUND

Study Officials

  • Michal Sotak, M.D., Ph.D.

    Military University Hospital, Prague

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jan Palenik, M.D.

CONTACT

Ladislav Šindelář, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 18, 2025

First Posted

November 25, 2025

Study Start

March 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

April 21, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations